SEC Form 4 · accession 0001456817-26-000013
TELA Bio, Inc. · TELA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Capper
Director
Period of report
Sep 14, 2026
Accepted (ET)
Sep 16, 2026 · 6:46 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001561921
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2026 | P | 25,000 | $1.0201 | A | 54,827 | D | |
| Common StockF2 | Sep 15, 2026 | P | 50,000 | $1.0588 | A | 104,827 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.9899 to $1.04. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- F2The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.01 to $1.10. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.